NCT04131959View on ClinicalTrials.gov

Ticagrelor CytoSorb Hemoadsorption

NATerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

May 4, 2021

Study Completion Date

May 4, 2021

Conditions
Emergent Cardiothoracic SurgeryBleedingDrug Removal
Interventions
DEVICE

CytoSorb 300 mL device

Intra-operative CytoSorb hemoadsorption of ticagrelor during cardiopulmonary bypass

Trial Locations (8)

B15 2TH

Queen Elizabeth Hospital, Birmingham

FY3 8NR

Blackpool Victoria Hospital, Blackpool

UB9 6JH

Harefield Hospital, Harefield

M13 9WL

Manchester Royal Infirmary, Manchester

S5 7AU

Northern General Hospital, Sheffield

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

G81 4DY

Golden Jubilee National Hospital, Glasgow

Sponsors

Lead Sponsor

CytoSorbents, Inc
All Listed Sponsors
lead

CytoSorbents, Inc

INDUSTRY